Abstract
IntroductionBoth primitive and metastatic splenic tumours represent less than 0.96% of all metastases. Clinical caseWe report the case of an 80-year-old woman, who had undergone surgery for invasive ductal carcinoma 3.5 years previously with neoadjuvant treatment. During follow-up, PET-CT revealed tumour recurrence in the splenic hilum. Laparoscopic splenectomy was performed, which was reported as an adenocarcinoma of mammary origin. DiscussionSplenic metastases are infrequent, and usually present as splenomegaly associated with abdominal discomfort. The symptoms of malignant splenic lesions are fever, constitutional syndrome, pleural effusion, and cachexia. Diagnosis of splenic metastases is usually carried out during oncological follow-up with computed tomography. Treatment is surgical resection, although there are no protocols for the treatment of splenic metastases. Survival increases after splenectomy due to metastasis. ConclusionsSplenectomy for splenic metastases is the most common treatment in these cases.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
